Search Results 91-100 of 2486 for ✔[광고텔레:TOOPPC] 구글레플리카광고 상단도배 카지노솔루션홍보 에볼루션알광고 구글에볼루션알광고 홀덤솔루션✔

  1. MediCool Protocol - Mayo Clinic

    The purpose of this study is to assess termination of atrial fibrillation (AF) following delivery of cold treatment to the oblique sinus using an experimental ...

  2. Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis

    The purpose of this study is to determine the prevalence of TTR-CA in a community-based cohort of moderate and severe aortic stenosis patients using 99mTc-PYP ...

  3. Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. A Study to Evaluate Rectal Cancer with Diffusion-Weighted and Dynamic Contrast Enhanced Perfusion-Weighted Magnetic Resonance Imaging - Mayo Clinic

    The purpose of this study is to analyze the apparent diffusion coefficient (ADC) from Diffusion-Weighted (DWI) in patients before, during the second week of and ...

  5. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

    Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...

  6. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Type: Fellowship; Duration: 1 year; School: Graduate Medical Education; Specialty: Laboratory Medicine & Pathology ...

  7. William J. Casey, III, M.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher William J. Casey III, M.D., is a plastic surgeon with special interests in microsurgery and general reconstructive surgery.

  8. A Study of DFRF4539A in Patients with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Anticipated time on study treatment is 1 year or until disease progression or unacceptable toxicity occurs. Participation eligibility. Participant eligibility ...

  9. AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL - Mayo Clinic

    About this study. This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult ...

  10. Geoffrey B. Johnson, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    The research of Geoffrey Johnson, M.D., Ph.D., a Mayo Clinic nuclear medicine specialist & thoracic radiologist, focuses on radiopharmaceutical cancer ...